MEI Pharma MEI Pharma to Present at Cantor Fitzgerald Global Healthcare Conference Live Webcast from New York on September 26th Tue, 19 Sep 2017 06:00:00 -0700 MEI Pharma Announces Exclusive License Agreement with Presage Biosciences for Voruciclib, An Oral, Selective CDK Inhibitor Clinical-Stage Asset in Validated Class of Drugs with Demonstrated Value Tue, 05 Sep 2017 13:05:00 -0700 MEI Pharma Reports Fiscal Year 2017 Results Company Begins New Fiscal Year with $53.6 Million in Cash Tue, 05 Sep 2017 05:30:00 -0700 MEI Pharma to Present at Two Upcoming Investor Conferences Live Webcasts from Boston on September 7th and New York on September 8th Thu, 31 Aug 2017 06:00:00 -0700 MEI Pharma to Host Fiscal Year End Conference Call on September 5, 2017 Tue, 29 Aug 2017 06:00:00 -0700